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http://www.cardiothoracicsurgery.org/content/9/1/136RESEARCH ARTICLE Open AccessOn-pump versus off-pump coronary artery bypass
surgery in patients older than 60 years: five-year
follow-up of MASS III trial
Rodrigo Morel Vieira de Melo1,2,4, Whady Hueb1,2,3*, Paulo Cury Rezende1,2, Eduardo Gomes Lima1,2,
Alexandre Ciappina Hueb1,2, José Antonio Franchini Ramires1,2 and Roberto Kalil Filho1,2Abstract
Background: We aim to evaluate in-hospital events and long-term clinical outcomes in patients over 60 years of
age with stable coronary artery disease and preserved left ventricular ejection fraction undergoing off-pump or
on-pump coronary artery bypass grafting.
Methods: The MASS III was a single-center randomized trial that evaluate 308 patients with stable coronary artery
disease and preserved ventricular function assigned for: 155 to off-pump and 153 to on-pump CABG. Of this, 176
(58.3%) patients were 60 years or older at the time of randomization (90 of-pump and 86 on-pump). The primary
short-term end point was a composite of myocardial infarction, stroke, and overall mortality occurring within 30 days
after surgery or before discharge, whichever was later. The primary long-term end point was death from any cause
within 5 years, non-fatal myocardial infarction between 30 days and 5 years, or additional revascularization between
30 days and 5 years.
Results: On-pump CABG had a higher incidence of 30-day composite outcome than off-pump CABG (15,1% and
5.6%, respectively; P = 0.036). However, after the multivariate analysis, this association lost statistical significance, P = 0.05.
After 5-year follow-up, there were no significant differences between both strategies of CABG in the composite end
points 16.7% and 15.1%; Hazard Ratio 1.07; CI 0.41 – 1.82; P = 0.71, for off-pump and on-pump CABG respectively.
Conclusions: On-pump and off-pump CABG achieved similar results of combined events at short-term and 5-year
follow-up.
Trial registration: Clinical Trial Registration Information—URL: http://www.controlled-trials.com. Registration number:
ISRCTN59539154.
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Several studies comparing off-pump coronary artery bypass
surgery (CABG) with on-pump CABG, in various patients
populations, failure to demonstrate a superiority of a tech-
nique over the other in clinical outcomes despite some dif-
ferences in postoperative complications [1-3]. Currently,
there is an attempt to identify patient subgroups in whom* Correspondence: mass@incor.usp.br
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article, unless otherwise stated.beating heart surgery is the preferred procedure, particu-
larly in those with a high risk profile [4-6].
Advanced age is associated with a higher prevalence of
preoperative comorbidities, reduced functional reserve,
and increased mortality and morbidity in patients under-
going coronary artery bypass grafting [7,8]. That becomes
a major concern as the number of elderly patients under-
going CABG surgery continues to increase [9,10]. Thus,
recent trials addressed for this specific population, did not
include data on long-term morbidity and mortality [5,6].
The MASS III was a randomized clinical trial that evalu-
ated postoperative outcomes and long-term clinical events
in patients with multivessel coronary artery disease, stableCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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coronary artery bypass grafting with and without extracor-
poreal circulation [3].
The main finding of the MASS III trial was that either
revascularization strategy provides similar rates of all-
cause mortality and major cardiovascular events at
5 years. The present post-hoc analysis aims to investigate
whether off-pump CABG strategy would be especially
advantageous for older patients undergoing CABG on
postoperatively outcomes and long-term follow-up.
Methods
Study design and treatment
Protocol details have been published previously [11]. In
brief, patients with angiographically documented proximal
multivessel coronary stenosis of >70% by visual assess-
ment, stable angina, and preserved ventricular function
were considered for inclusion. Patients were enrolled and
randomized if the surgeons agreed that revascularization
could be achieved by either strategy. All angiograms were
reviewed, and a surgical plan was documented before
randomization. Patients were eligible if they were referred
for isolated coronary bypass surgery for the first time and
an off-pump procedure was deemed technically feasible.
In this post-hoc analysis, we included only patients with
60 years or older at the time of randomization. Patients
were excluded if they required emergency or concomitant
major surgery, unstable angina requiring emergency revas-
cularization, ventricular aneurysm requiring repair, and a
left ventricular ejection fraction of less than 40%, previous
stroke, peripheral vascular disease or chronic renal insuffi-
ciency with a estimated creatinine clearance of less than
60 mL/min. Patients were also excluded if they were un-
able to provide written informed consent. The Ethics
Committee of the Heart Institute of the University of São
Paulo - Medical School, in São Paulo Brazil, approved the
trial, and all procedures were performed in accordance with
the Helsinki Declaration. All subjects gave informed con-
sent. Trial operators were required to perform optimum
coronary revascularization in accordance with current best
practices. The procedure was performed by surgeons expe-
rienced in both on-pump and off-pump bypass surgery.
Stabilization devices were used during off-pump surgery to
allow the safe construction of the anastomosis of the graft
with the recipient artery.
Qualification of surgeons
Each operation was performed by a surgeon with more
than 20 years of experience and having completed more
than 100 procedures per year in both techniques.
Study end points
The primary short-term end point was a composite of myo-
cardial infarction, stroke, and overall mortality occurringwithin 30 days after surgery or before discharge, whichever
was later. The primary composite long-term end point was
death from any cause within 5 years, non-fatal myocardial
infarction between 30 days and 5 years, or additional revas-
cularization between 30 days and 5 years. Stroke was de-
fined as a focal brain injury that persisted for >24 hours,
combined with an increase in disability of at least 1 grade
on the Ranking scale [12]. Myocardial infarction within
7 days from the coronary artery bypass grafting procedure
was considered if elevation of CK-MB or troponin 5 times
or more the 99th percentile.
Follow-up
Adverse and other clinical events were tracked from
randomization. Patients were assessed with follow-up
visits every 6 months at the Heart Institute.
Statistical analysis
All data were analyzed on an intention-to-treat principle
beginning immediately after randomization. The risk of an
event after on-pump surgery was compared with that after
off-pump surgery, and the results are presented as the ab-
solute difference with the corresponding 95% confidence
intervals. Values are expressed as mean (±SD). Dichotom-
ous data were compared by the χ2statistic or Fisher exact
test. Continuous variables that were not distributed nor-
mally, as evaluated through the Kolmogorov–Smirnov
test, were compared by the Mann–Whitney test. Continu-
ous variables with a normal distribution were compared
by the Student’s t test. All reported probability values are
2-sided. Event-free survival was graphically compared by
using Kaplan–Meier curves. Event rates were compared
with the use of the log-rank test of time to the first event
after randomization. Relative risks were expressed as haz-
ard ratios with associated confidence intervals and were
derived from the Cox proportional-hazards model. A
probability value of P < 0.05 was considered statistically
significant. Multivariable analysis with logistic regression
(short-term end point) and Cox proportional-hazards
model (long-term end point) were used when appropri-
ated, including variables with a possible association (P <
0.2) with the combined events. These analyses were per-
formed with SPSS, version 17.0 (SPSS, Inc).
Results
Between March 2001 and March 2006, 308 patients with
stable coronary artery disease were assigned to CABG:
153 to on-pump surgery and 155 to off-pump surgery.
From those, 176 (58.3%) patients were 60 years or older at
the time of randomization (90 off-pump CABG and 86
on-pump CABG). The two groups were well-matched for
baseline demographic, clinical, and angiographic charac-
teristics and are summarized in Table 1. The mean age
was 65.7 in the on-pump patients and 67.1 in the off-
Table 1 Baseline characteristics
On-pump
CABG n = 86
Off-pump
CABG n = 90
P
Age (years) 66.5 ± 5.1 67.9 ± 5.1 0.07
Male gender n (%) 64 (74.4) 62 (68.9) 0.50
Diabetes n (%) 32 (37.2) 29 (32.2) 0.029
Hypertension 58 (67.4) 61 (67.8) 1.0
Current smoke n (%) 17 (19.8) 14 (15.6) 0.74
Previous MI n (%) 35 (40.7) 44 (48.9) 0.29
Angina n (%) 81 (94.2) 84 (93.3) 1.0
Angina CCS III-IV n (%) 10 (12.3) 15 (17.9) 0.38
Ejection fraction 65.1 ± 6.4 65.8 ± 9.3 0.57
Cholesterol mg/dL 213 ± 48.6 211 ± 40.9 0.74
LDL-c mg/dL 134 ± 45.1 132 ± 34.8 0.68
HDL-c mg/dL 42 ± 9.2 42 ± 10.2 0.82
Triglycerides mg/dL 175 ± 122 187 ± 111 0.52
3-Vessel CAD n (%) 73 (84.9) 67 (74.4) 0.09
CABG = coronary artery bypass graft; MI = myocardial infarction;
CCS = Canadian Cardiovascular Society; CAD = coronary artery disease.
Table 2 Univariate predictors of short-term combined
events
With combined
events n = 18
Without combined
events n = 158
P
On-pump CABG n (%) 13 (72.2) 73 (46.2) 0.04
Age, years 65.3 ± 4.2 67.4 ± 5.2 0.10
Male gender n (%) 11 (61.1) 115 (72.8) 0.41
Hypertension n (%) 14 (77.8) 105 (66.5) 0.43
Diabetes n (%) 4 (22.2) 57 (36.1) 0.30
Current smoke n (%) 6 (33.3) 25 (15.8) 0.10
Angina n (%) 11 (61.1) 115 (72.8) 0.41
3-Vessel CAD n (%) 16 (88.9) 124 (78.5) 0.37
Previous MI n (%) 17 (94.4) 148 (93.7) 1.0
Grafts, mean 2.9 ± 0.58 2.7 ± 0.65 0.25
Treated vessels, mean 3 ± 0.59 2.8 ± 0.74 0.38
LIMA graft n (%) 17 (94.4) 152 (96.2) 0.53
CABG= coronary artery bypass graft; MI =myocardial infarction; CAD = coronary
artery disease; LIMA = Left Internal Mammary Artery.
Table 3 Events at 30 days
On-pump CABG Off-pump CABG P
Myocardial infarction n (%) 10 (11.6) 4 (4.4) 0.09
Stroke n (%) 3 (4.4) 1 (1.1) 0.36
Death n (%) 0 0 -
Combined events n (%) 13 (15.1) 5 (5.6) 0.04
CABG = coronary artery bypass graft.
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groups and there was no lost of follow-up. The median
follow-up was 5 years.
Patients randomized to on-pump CABG were more
likely to achieve complete revascularization than off-
pump CABG with a non-significant trend, (52.3%) vs
(38.9%) p = 0.096, respectively. There was no difference
in the amount of grafts of left internal thoracic artery
in the two revascularization strategies: 81 (94.2%) vs 88
(97.8%) for on-pump and off-pump CABG respect-
ively (P = 0.27). Moreover, patients undergoing on-
pump surgery showed a higher average total number
of grafts 2.9 ± 0.64 vs 2.6 ± 0.61, P = 0.002 and a
higher number of vessels treated 3.0 ± 0.71 vs 2.7 ±
0.68, P = 0.001.
On the short-term end point, the univariate analysis
demonstrated that on-pump CABG patients had a
higher incidence of combined events before discharge
or within 30 days after the procedure as compared
with off-pump CABG: 13 (15.1%) vs 5 (5.6%); P = 0,04
(Table 2) (Table 3). After the multivariate analysis, with
the inclusion of the following variables: on-pump sur-
gery, current smoke and age, performing on-pump
CABG showed a trend for association with the short-
term combined end point, p = 0.05.
After 5-year follow-up, on the univariate analysis,
there were no significant differences between both
strategies of CABG in the composite end points 15
(16.7%) vs 13 (15.1%), (Hazard Ratio 1.07; CI 0.41 –
1.82; P = 0.71) for off-pump and on-pump CABG re-
spectively (Figure 1).Discussion
There is currently an attempt to compare clinical out-
comes in the two techniques of myocardial revasculariza-
tion, on short and long-term follow-up. So far, previous
studies have either underrepresented an elderly high-risk
population or had lack of data on long-term follow-up.
In this post hoc analysis, we seek to evaluate a popula-
tion at higher surgical risk selected by having over 60 years
old at the time of randomization, and assess whether off-
pump CABG add clinical benefit specifically on 5-year
follow-up.
In the Rooby Trial, with follow-up results available so
far 1 year, both techniques had similar clinical events at
30 days but with a lower rate of combined events at
1 year favoring the on-pump group [1].
The CORONARY study aimed to compare the two
techniques in a population of greater surgical risk
(older patients with a higher cardiovascular risk),
showing no difference in clinical events at 30 days and
1-year follow-up [2].
The MASS-3 was a randomized, single-center study
that evaluated two strategies for elective CABG in pa-
tients with stable coronary artery disease and preserved
ventricular function. The main result was that there was
Figure 1 Kaplan–Meier estimates of survival free of combined events after surgery.
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two groups following 5 years [3].
Specifically in the population with advanced age, the
recent studies GOPCABE and DOORS, showed no differ-
ence in clinical events on short and intermediate follow-
up [5,6].
Despite being a post-hoc analysis in a specific popula-
tion of the original trial, both study groups had well-
balanced baseline characteristics. Most of our patients had
3-vessel CAD and complete revascularization was the goal
in both groups, but like previous studies, off-pump surgery
was associated with a lower proportion of complete revas-
cularization. This was evidenced by a lower average in
total number of grafts and number of vessels treated on
the off-pump group.
In the 30-day analysis, patients undergoing off-pump
surgery had a lower incidence of combined events on
the univariate analysis, driven by a lower rate of stroke
and myocardial infarction. However, after the multivari-
ate model, this analysis lost statistical significance reveal-
ing only a trend towards association.
There is some contradictory data in the literature
assessing however off-pump CABG in patients with ad-
vanced age can significantly reduce rates of perioperative
overall complications. Observational studies have sug-
gested that off-pump technique might prevent stroke
and postoperative myocardial infarction [13-17]. How-
ever, more recent trials did not confirm any benefit for
any technique over the other on rates of in-hospital
complications [5,6].
The results of 5-year follow-up confirm the data ob-
tained in previous studies with short to intermediatefollow-up that both techniques are safe and similar in
terms of clinical events in patients with advanced age.
The strength of this study lies on the long-term follow-
up in a population with a higher surgical risk, with no loss
to follow-up.
There were some limitations. First, we used the cut-off
level of troponin and CK-MB for the diagnosis of myo-
cardial infarction after the procedure of 5 times the 99th
percentile, consistent with the definition used at the time
of the study, which is a lower limit than current recom-
mendations of the third definition of myocardial infarc-
tion [18]. Although we selected only patients older than
60 years at the time of randomization, the average age of
our patients was not very high. There was only assess-
ment of clinical outcomes of our patients, as graft pa-
tency and neurocognitive evaluation were not assessed
in this study. In addition, there is no data concerning
stenosis of carotid artery and cerebrovascular history for
comparison between the two groups. Finally, this post-
hoc analysis was not pre-specified in the original design
of the MASS III Trial and therefore, subject to the biases
inherent of this analysis.Conclusion
In our study, patients older than 60 years undergoing
coronary surgical revascularization achieved similar rates
of composite end points on short-term and long-term
follow-up with on-pump and off-pump CABG.Competing interests
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